Serge P Eholié

Summary

Publications

  1. pmc Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008
    Yao Abo
    Programme PAC CI, Centre Hospitalier Universitaire CHU de Treichville, 18 BP 1954, Abidjan, Cote d Ivoire
    BMC Infect Dis 13:607. 2013
  2. pmc HIV treatment and care in resource-constrained environments: challenges for the next decade
    Serge Paul Eholie
    Department of Infectious Diseases and Dermatology, Unit of Training and Research in Medical Sciences, University of Abidjan, Cote d Ivoire
    J Int AIDS Soc 15:17334. 2012
  3. ncbi request reprint Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Côte d'Ivoire
    Serge Paul Eholie
    Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Treichville, Abidjan, Cote d Ivoire
    J Acquir Immune Defic Syndr 45:355-8. 2007
  4. doi request reprint Avascular osteonecrosis of the femoral head in three West African HIV-infected adults with heterozygous sickle cell disease
    Serge P Eholié
    Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Cote d Ivoire
    Antivir Ther 14:1011-4. 2009
  5. ncbi request reprint [Impact of access to antiretroviral therapy in Côte d'Ivoire]
    S P Eholie
    Departement des Maladies Infectieuses et Tropicales, Ministere de la Sante, Abidjan, Cote d Ivoire
    Med Trop (Mars) 69:520-4. 2009
  6. pmc Antiretroviral therapy response among HIV-2 infected patients: a systematic review
    Didier K Ekouevi
    Programme PACCI, Site ANRS, Abidjan, Cote d Ivoire
    BMC Infect Dis 14:461. 2014
  7. pmc Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa
    Eugene Messou
    Programme PAC CI ANRS, Abidjan, Côte d Ivoire INSERM, Centre 897, France University of Bordeaux, ISPED, France Laboratoire de Virologie, Universite Paris Descartes, Sorbonne Paris Cité, AP HP, CHU Necker Enfants Malades, Paris CeDReS, CHU de Treichville, Abidjan, Côte d Ivoire and Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Cote d Ivoire
    J Acquir Immune Defic Syndr 64:211-9. 2013
  8. pmc Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of the West African Database to evaluate AIDS collaboration
    Boris K Tchounga
    Centre INSERM U897 Epidemiologie Biostatistique, ISPED, Universite de Bordeaux, Bordeaux, France Inserm U897, ISPED, Universite de Bordeaux, Bordeaux, France Programme PACCI, Site de recherche ANRS, Abidjan, Cote d Ivoire
    J Int AIDS Soc 17:19064. 2014
  9. pmc The spectrum of cancers in West Africa: associations with human immunodeficiency virus
    Aristophane Tanon
    Service de Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Cote d Ivoire
    PLoS ONE 7:e48108. 2012
  10. pmc Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire
    Henriette A Vanga-Bosson
    Programme PAC CI, Abidjan, Cote d Ivoire
    Malar J 10:105. 2011

Collaborators

Detail Information

Publications12

  1. pmc Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008
    Yao Abo
    Programme PAC CI, Centre Hospitalier Universitaire CHU de Treichville, 18 BP 1954, Abidjan, Cote d Ivoire
    BMC Infect Dis 13:607. 2013
    ..We estimated the incidence of serious morbidity among HIV-infected adults receiving ART in one of these HIV routine care center in sub-Saharan Africa...
  2. pmc HIV treatment and care in resource-constrained environments: challenges for the next decade
    Serge Paul Eholie
    Department of Infectious Diseases and Dermatology, Unit of Training and Research in Medical Sciences, University of Abidjan, Cote d Ivoire
    J Int AIDS Soc 15:17334. 2012
    ..In order for us to let it grow, long-term cost-effectiveness approach and life-saving evidence-based programming should replace short-term budgeting approach...
  3. ncbi request reprint Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Côte d'Ivoire
    Serge Paul Eholie
    Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Treichville, Abidjan, Cote d Ivoire
    J Acquir Immune Defic Syndr 45:355-8. 2007
    ..To estimate adherence to highly active antiretroviral therapy (HAART) and its determinants in HIV-infected adults followed in field conditions in Abidjan...
  4. doi request reprint Avascular osteonecrosis of the femoral head in three West African HIV-infected adults with heterozygous sickle cell disease
    Serge P Eholié
    Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Cote d Ivoire
    Antivir Ther 14:1011-4. 2009
    ..Future studies should explore whether these risk factors might include haemoglobin AS sickle cell disease, a common trait in the West African general population...
  5. ncbi request reprint [Impact of access to antiretroviral therapy in Côte d'Ivoire]
    S P Eholie
    Departement des Maladies Infectieuses et Tropicales, Ministere de la Sante, Abidjan, Cote d Ivoire
    Med Trop (Mars) 69:520-4. 2009
    ..Convincing results have been obtained in the management of PLWHA. Nevertheless greater funding and commitment must be given to management of opportunistic infections and side effects and to development of nutrition support services...
  6. pmc Antiretroviral therapy response among HIV-2 infected patients: a systematic review
    Didier K Ekouevi
    Programme PACCI, Site ANRS, Abidjan, Cote d Ivoire
    BMC Infect Dis 14:461. 2014
    ..We conducted a systematic review on treatment outcomes among HIV-2 infected patients on ART, focusing on the immunological and virological responses in adults...
  7. pmc Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa
    Eugene Messou
    Programme PAC CI ANRS, Abidjan, Côte d Ivoire INSERM, Centre 897, France University of Bordeaux, ISPED, France Laboratoire de Virologie, Universite Paris Descartes, Sorbonne Paris Cité, AP HP, CHU Necker Enfants Malades, Paris CeDReS, CHU de Treichville, Abidjan, Côte d Ivoire and Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Cote d Ivoire
    J Acquir Immune Defic Syndr 64:211-9. 2013
    ..In sub-Saharan Africa, most HIV-infected patients receive antiretroviral therapy (ART) without virological monitoring. Longitudinal data on secondary resistance are rare...
  8. pmc Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of the West African Database to evaluate AIDS collaboration
    Boris K Tchounga
    Centre INSERM U897 Epidemiologie Biostatistique, ISPED, Universite de Bordeaux, Bordeaux, France Inserm U897, ISPED, Universite de Bordeaux, Bordeaux, France Programme PACCI, Site de recherche ANRS, Abidjan, Cote d Ivoire
    J Int AIDS Soc 17:19064. 2014
    ..This study aimed at confirming the classification of HIV-2 and HIV-1&2 dually reactive patients followed up in the HIV-2 cohort of the West African Database to evaluate AIDS collaboration...
  9. pmc The spectrum of cancers in West Africa: associations with human immunodeficiency virus
    Aristophane Tanon
    Service de Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Cote d Ivoire
    PLoS ONE 7:e48108. 2012
    ..Our objective was to estimate the association between HIV infection and selected types of cancers among patients hospitalized for diagnosis or treatment of cancer in West Africa...
  10. pmc Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire
    Henriette A Vanga-Bosson
    Programme PAC CI, Abidjan, Cote d Ivoire
    Malar J 10:105. 2011
    ..Data on IPT-SP coverage and factors associated with placental malaria parasitaemia and low birth weight (LBW) are scarce in Côte d'Ivoire...
  11. pmc Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire
    Eric N Ouattara
    Centre Inserm 897, University of Bordeaux, Bordeaux, France ISPED, University of Bordeaux, Bordeaux, France Programme PAC CI ANRS Research Site, CHU de Treichville, Abidjan, Côte d Ivoire Division of General Medicine and the Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA Department of Infectious and Tropical Diseases, Bichat Claude Bernard University Hospital, Paris, France Equipe Atip Avenir Inserm U738, University Paris Diderot, Paris, France Department of Orthopedics, Brigham and Women s Hospital, Boston, MA Center for AIDS Research, Harvard University, Boston, MA Harvard Medical School, Boston, MA Departments of Biostatistics, Boston University School of Public Health, Boston, MA Department of Infectious and Tropical Diseases, Treichville University Hospital, Abidjan, Côte d Ivoire Divisions of Infectious Disease and the Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA Division of Infectious Disease, Brigham and Women s Hospital, Boston, MA Department of Epidemiology and Public Health, Yale School of Public Health, New Haven, CT Department of Epidemiology, Germany
    J Acquir Immune Defic Syndr 66:294-302. 2014
    ..We examined the clinical impact and cost-effectiveness of making third-line ART available in Côte d'Ivoire...
  12. pmc Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire
    Didier K Ekouevi
    Programme PAC CI, Abidjan, Cote d Ivoire
    J Acquir Immune Defic Syndr 56:183-7. 2011
    ..An increasing number of HIV-infected women become pregnant while receiving efavirenz (EFV). We compared the pregnancy outcomes of women exposed to EFV and to nevirapine (NVP) during the first trimester...